Shelter Pharma has informed that the Company has received order from Genet International in the normal course of business. The aforesaid export orders represent a significant milestone in the Company's growth trajectory and reflect the company’s growing presence in international markets. The execution of these orders is expected to further strengthen the Company's global presence, enhance its export business, and contribute positively to its revenue growth and overall business expansion.
The above information is a part of company’s filings submitted to BSE.